About Horiba Medical Illustration

The HORIBA Medical Segment designs, develops and distributes worldwide, in vitro diagnostic systems mainly destined for biological analysis in medical laboratories. These automated analyzers meet the needs of various users including patients, doctors, private laboratories, clinics and university hospitals. HORIBA expertise in in vitro diagnostics is one of the most respected in hematology worldwide and contribute today to the health of tomorrow.

Key indicators

  • Over 1,100 employees
  • 4 production centers (Japan, China, France, Brazil)
  • 2 R&D centers (Japan, France)
  • Around 100 distributors
  • 13 local/direct operations
  • Around 30,000 laboratories supplied worldwide

Feb 14, 2019 - 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine

Read more

Feb 6, 2019 - Based on innovative ‘data mining’ techniques and combined with Full Blood Count, the Malaria...

Read more

Feb 6, 2019 - HORIBA Medical announces the availability of a D-Dimer reagent for their semi-automated Hemostasis...

Read more